Related Experiment Video
Updated: Mar 7, 2026

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56
Jiao Wang1,2, Juha Okkeri3,4, Karolina Pavic3,4
1Department of Biological Structure, University of Washington, Seattle, WA, USA.
Abstract:
Protein phosphatase 2A (PP2A) is a critical human tumor suppressor. Cancerous inhibitor of PP2A (CIP2A) supports the activity of several critical cancer drivers (Akt, MYC, E2F1) and promotes malignancy in most cancer types via PP2A inhibition. However, the 3D structure of CIP2A has not been solved, and it remains enigmatic how it interacts with PP2A. Here, we show by yeast two-hybrid assays, and subsequent validation experiments, that CIP2A forms homodimers. The homodimerization of CIP2A is confirmed by solving the crystal structure of an N-terminal CIP2A fragment (amino acids 1-560) at 3.0 Å resolution, and by subsequent structure-based mutational analyses of the dimerization interface. We further describe that the CIP2A dimer interacts with the PP2A subunits B56α and B56γ. CIP2A binds to the B56 proteins via a conserved N-terminal region, and dimerization promotes B56 binding. Intriguingly, inhibition of either CIP2A dimerization or B56α/γ expression destabilizes CIP2A, indicating opportunities for controlled degradation. These results provide the first structure-function analysis of the interaction of CIP2A with PP2A/B56 and have direct implications for its targeting in cancer therapy.
Insights
Cancerous inhibitor of protein phosphatase 2A (CIP2A) forms homodimers, enabling interaction with PP2A subunits. This structural insight reveals new therapeutic strategies for targeting CIP2A in cancer.
Area of Science:
- Molecular Biology
- Structural Biology
- Cancer Research
Background:
- Protein phosphatase 2A (PP2A) is a crucial human tumor suppressor.
- Cancerous inhibitor of PP2A (CIP2A) promotes cancer by inhibiting PP2A and activating oncogenic pathways.
- The structural basis of CIP2A-PP2A interaction remained unknown.
Purpose of the Study:
- To elucidate the 3D structure of CIP2A and its interaction mechanism with PP2A.
- To investigate the role of CIP2A homodimerization in its function.
- To identify potential therapeutic targets for CIP2A in cancer treatment.
Main Methods:
- Yeast two-hybrid assays for interaction studies.
- X-ray crystallography to determine the structure of a CIP2A fragment.
- Structure-based mutational analysis to probe the dimerization interface.
- Expression analysis of PP2A subunits B56α and B56γ.
Main Results:
- CIP2A forms homodimers, confirmed by structural and mutational analyses.
- The crystal structure of the N-terminal CIP2A fragment (1-560) was solved at 3.0 Å resolution.
- CIP2A dimer binds to PP2A subunits B56α and B56γ via a conserved N-terminal region.
- Dimerization enhances CIP2A binding to B56 proteins.
- Inhibition of CIP2A dimerization or B56α/γ expression leads to CIP2A destabilization and degradation.
Conclusions:
- This study provides the first structure-function analysis of CIP2A interaction with PP2A/B56.
- CIP2A homodimerization is critical for its binding to PP2A and oncogenic function.
- Targeting CIP2A dimerization or B56 expression offers novel therapeutic avenues for cancer treatment.
Related Concept Videos
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Anaphase Promoting Complex
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway

